Article Details

FDA accepts application for nirsevimab against RSV in infants - Contemporary Pediatrics

Retrieved on: 2023-01-05 19:22:43

Tags for this article:

Click the tags to see associated articles and topics

FDA accepts application for nirsevimab against RSV in infants - Contemporary Pediatrics. View article details on HISWAI: https://www.contemporarypediatrics.com/view/fda-accepts-application-for-nirsevimab-against-rsv-in-infants

Excerpt

Protection is timely, direct, and rapid, as the immune system does not need to activate for monoclonal antibodies to function.

Article found on: www.contemporarypediatrics.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up